Cargando…
Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors
The molecular chaperone HSP90 plays an essential role in cancer occurrence and development. Therefore, it is an important target for the development of anticancer drugs. 1,3-Dibenzyl-2-aryl imidazolidine (8) is a previously reported inhibitor of HSP90; however, its anticancer activity is poor. In th...
Autores principales: | Yang, Man, Li, Chenyao, Li, Yajing, Cheng, Chen, Shi, Meiyun, Yin, Lei, Xue, Hongyu, Liu, Yajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518286/ https://www.ncbi.nlm.nih.gov/pubmed/36120957 http://dx.doi.org/10.1080/14756366.2022.2124407 |
Ejemplares similares
-
Probing Structural Features and Binding Mode of 3-Arylpyrimidin-2,4-diones within Housefly γ-Aminobutyric Acid (GABA) Receptor
por: Li, Qinfan, et al.
Publicado: (2011) -
5,7-Bis(benzyloxy)-2-[4-(benzyloxy)phenyl]-4H-chromen-4-one
por: Ren, Xu-Hong, et al.
Publicado: (2009) -
1,4-Bis(benzyloxy)-2-tert-butylbenzene
por: Wang, Guo-wei, et al.
Publicado: (2008) -
4-Benzyloxy-3-(2,4-dichlorophenyl)-1-oxaspiro[4.5]dec-3-en-2-one
por: Xu, Liang-zhong, et al.
Publicado: (2009) -
5,7-Bis(benzyloxy)-2-phenyl-4H-chromen-4-one
por: Nallasivam, Angannan, et al.
Publicado: (2008)